REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx, an emerging leader in interventional pulmonology, announced today that multiple clinical abstracts examining the diagnostic and therapeutic utility of ...
LONDON & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Positive results from the IMPACT study demonstrate that patients with homogeneous emphysema benefit from treatment with Pulmonx Corporation’s ...
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback